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1177-135 Lipid-Lowering Therapy With Pravastatin Reduces 
Coronary Plaque Volume: Role of High-Density 
Lipoprotein Cholesterol Containing Apolipoprotein A-l 
Shiqemasa Tani. lkuyoshi Watanabe, Sumito Oguchi. Takeo Anazawa, Hiroshi 
Takahashi. Kazumiki Nom&, Norio Miya, Kazutoshi Ishikawa, Michiaki Matsumoto. 
Tadamasa Nosaka, Tikara Kobari, Takuya Miyazawa, Kiyotaka Furukawa, Takashi 
Miyamoto, Ken Nagao, Katsuo Kanmatsuse. Nihon University Surugadai Hospital, 
Tokyo, Japan 
POSTER SESSION 
1178 Mechanisms of Angiogenesis and Cell 
Therapies 
Background: Atheroprotective high-density lipoprotein cholesterol (HDL-C) and its 
major structural protein, apolipoprotein Al (apoA1) may inhibit plaque expansion by 
mediating reverse cholesterol transport. However, whether statin-induced increased the 
level of HDL-C affects the volume of coronary atherosclerotic plaque is not fully under- 
stood. Therefore we investigated the relationship between HDL-C levels and plaque 
appearances with statin therapy. 
Methods and Results: 50 patients undergoing percutaneous coronary intervention (PCI) 
were studied with Intravascular ultrasound (IVUS) after PCI and at a 6-month follow-up 
period of treatment with pravastatin. In non-dilated matched coronary segments, volu- 
metric analyses were performed with 3.dimensional (3-D) IVUS system. After 6months 
therapy, pravastatin significantly reduced plasma levels of total cholesterol and low-den- 
sity lipoprotein cholesterol (LDL-C), and oxidized-LDL by 24, 25, and 15%, respectively, 
and increased HDL-C and apoA1 levels by 10.2 and 9.2% (p<O.OOl vs. baseline levels 
for all variables). BD-IVUS examination revealed that plaque volume was significantly 
decreased (baseline vs. 6 months: 46.4*30.3 vs. 39.0+26.2mm3, pcO.OOOl), whereas no 
significant differences in lumen and vessel volume are observed (64.9A39.7 vs. 
69.0*37.1mm3, p=O.lO; 113.4i63.7 vs. 106.0~57.4mn?, ~30.13). Furthermore, % 
changes in plaque volume were inversely correlated with those in plasma levels of HDL- 
C (r=-0.54, pcO.0001) and apoA1 (r=-0.43, pcO.O5), but not with those in the levels of 
total cholesterol (r=0.23, p=O.l2) and LDL-C (rz0.24, p=O.25), and oxidized-LDL (r=0.12, 
p=0.35). 
Conclusions: Our results demonstrated that pravastatin-induced increased the levels of 
HDL-C and apoA1 were associated with a comparable, significant reduction in the 
amount of plaque volume. We suggest that pravastatin therapy even at a 6-month follow 
up may enhance the role of HDL-C containing apoA-I in reverse cholesterol transport. 
1177-136 Statins Inhibit Calcification of Aortic Valve Interstitial 
Cells 
Bing Wu. Sammy Elmanah Emile Ft. Mohler, Ill, University of Pennsylvania School of 
Medicine, Philadelphia, PA 
Background: Retrospective clinical data Indicate that HMG-CoA reductase inhibitors 
(statins) limit calcification in atherosclerotic coronary arteries and aortic valves. However 
the mechanism of action of statins in prevention of calcification is unknownMethods: 
We evaluated the effects of statins on cardiac valve calcificatmn in vitro using a previ- 
ously validated cell culture model of valve calcification. Porcine aortic valve interstitial 
cells were incubated in varying concentrations of simvastatin and pravastatln (0 1, 0.3. 
and 0.6 FM) to determine if these drugs inhibit calcific nodule formabon. Mevalonate (1 .O 
FM), metabolite of HMG-CoA reductase, was given to determine if the mechanism of 
inhibition involves the cholesterol biosynthetic pathway. Alkaline phosphatase activity, a 
marker of osteoblastlc differenbation, was measured in cell lysates. Results: Simvastatin 
and pravastatin inhibited calcific nodule formation in a dose-dependent manner and there 
was a partial reversal of effect with mevalonate (Figure). Alkaline phosphatase activity 
was reduced with statins, also in a dose-dependent manner. Conclusions: Statins drugs 
inhibit valve calcification partially through inhibition of cholesterol biosynthetic pathway 
and alkaline phosphatase. These data provide further evidence that statins will prove 
useful therapy for calcific cardiac valve disease 
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1178-l 37 Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 
Jalees Rehman, Jingling Li. Lakshml Parvathaneni, Vipul R. Panchal, Jo Mahenthiran, 
Keith L. March, Indiana University, School of Medicine, Indianapolis, IN, Indiana Center 
for Vascular Biology and Medicine, Indianapolis. IN 
Introduction: Exercise exerts a pro-angiogenic effect by mechanisms which are not fully 
understood. Circulating endothelial progenitor cells (EPCs) have been shown to partici- 
pate in formation of new blood vessels. Since exercise acutely increases circulating lym- 
phocyte number, we investigated whether exercise may act in a pro-angiogenic manner 
wa increases in circulating EPCs. 
Methods: Subjects without evidence of coronary artery disease were exercised on a 
treadmill or bicycle to a mean of 92*2 % of their predicted maximum heart rate. Blood 
samples were obtained before and immediately after exercise. Whole blood was ana- 
lyzed for the stem / progenitor cell marker AC133 (n=6) by flow cytometry. EPCs were 
isolated as previously described by plating the mononuclear cell fraction on a fibronectin- 
coated plate m EGM-P-MV media (ClonetIcs) and discarding non-adherent cells (n=9). 
Adherent EPCs were counted, and conditioned media was collected on a subset of the 
cell samples (n=5). The conditioned media was assayed for the angiogenic hepatocyte 
growth factor (HGF), which IS not present in EGM-2.MV media. Statistical analysis was 
performed using a paired t-test comparing pre- and post-exercise values. 
Results: Dynamic exercise significantly Increased the number of circulating AC133+ 
cells from 1307k.332 cells/ml to 22722511 cells/ml of blood (p=O.O22). Exercise also 
increased the number of adherent EPCs isolated from peripheral blood, by plating and 
culturing, from 7694+2586 cells/ml of blood to 19656+5716 cells/ml (p=O.O06). The 
adherent cells were equipotent m their ability to secrete HGF before and after exercise 
(44.2tl3.3 ng/106 cells vs 35.1 e7.0 ng/lOs cells, p=not significant). 
Conclusions Exercise can acutely increase the number of circulating cells which 
express the stem I progenitor cell marker AC133 as well as the EPC cells Isolated by 
plating and culturing. The latter cells also secrete the angiogenic growth factor HGF, 
which may in turn mediate some of their angiogenic effects. These findings suggest a 
novel means by which exercise may be cardmprotective. Furthermore, these results may 
also contribute to our understanding of stem and progenitor cell mob!lization. 
1178-l 38 lntramyocardial Delivery of Bone Marrow-Derived 
Mesenchymal Stem Cells Improves Myocardial 
Contractility in a Chronic lschemic Model 
Emerson C. Perin, Yong J. Geng, Andre Luiz S. Sousa, Guilherme V. Sllva. Stephanie 
Coulter, Jmg Lin, Judy Ober, Bradley J. Martin, James T. Wlllerson, Texas Heart 
Institute, Houston, TX 
Background: hksemnchymal stem cell (MSC) adminlstration has shown promising 
results for treatment of LV diysfunction in the acute Ml model. We sought to evaluate the 
safety and efficacy of intramyocardial delivery of allogeneic MSCs in a chronic ischemia 
model.. 
Methods: Allogeneic MSCs of dogs were cultured, expanded in vitro. Twelve healthy 
adult dogs were submitted to ameroid constnctor implant (proximal LAD) with diagonal 
branch ligation. Surgical intramyocardial injections (IMI) of 100x10s MSCs (10 ml) were 
distributed over 20 sites in the anterior wall in 6 animals(MSC group). The control group 
(n=6) received saline injectlons in the same manner. Left coronary angiography was per- 
formed immediately before IMI and 30 days after to certify ameroid constriction and 
assess anatomy. Echo was performed at baseline before ameroid implant and at 30 days 
(immediately before IMI) and at 30 days after IMI to assess LV ejection fraction (EF). 
Results: IMls were performed wcthout complicationss in all animals. Coronary angiogra- 
phy was unchanged at 30 and 60 days. Serial LVEF in the treatment and control groups 
are shown in table l(a vs. b p=O.6; c vs.d p=O.5; e vs. f p= 0.02). 
Conclusion: These results suggest that MSC injection did not result in a marked inflam- 
matory response when compared to controls.lmprovement in LV function was shown in 
the MSC group as compared to controls. 
Comparison of LVEF m MSC vs. Control group 
MSCs (n=6) 
Control (n=6) 
Baseline 30 d after ameroid 60 d after ameroid / 
/before IMI 30 d after IMI 
55 * 7 (a) 43* 10 (C) 48?17 (s) 
56 f 8 (b) 37i 13 (d) 26*14(f) 
1178-139 Transepicardial Autologous Bone Marrow 
Transplantation in a Porcine Nonreperfused Myocardial 
Infarction Model: Angiogenesis or Myogenesis? 
Laurent Leborgne, Jana A. Fournadiiev, Rajbabu Pakala, Hamid Yazdl. Edward F. 
Cheneau, Elias Rivera, Roswitha Wolfram, David Hellinga. Rufus Seaborn. Renu 
Vlrmani. Ron Waksman, WashIngton Hospital Center, Washington, DC, Armed Forces 
Institute of Pathology, Washmgton, DC 
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Background: Bone marrow (BM) derived stem cells secrete multiple growth factors and 
have been shown to differentiate to cardiomyocytes and endothelial cells in mice. This 
study evaluated the effect of trans-epicardial BM cell transplantation in a porcine non- 
rep&used myocardial infarction model. 
Methods: In 14 domestic pigs, myocardial infarction was created by occludmg the first 
diagonal artery with coils. Twenty-eight days later, Iliac crest BM cells were aspirated, fil- 
tered, labeled with bromodeoxyuridine (BrdU) and cultured for 46 hrs Injections of 0.2 ml 
(-1.5 million cells/ml) (BM. n=l 1 pigs and saline, n=3 pigs) were evenly distributed lcm 
apart in the scar (6 injections) and around the scar (6 InJections). Animals were sacrificed 
at 4 (n=3), 14 (n=4) and 28 days (n=7) for histology and immunohistochsmistry analysis. 
Tram-epicardial echocardiography was performed at the time of injection and at sacrifice 
to assess reglonal contractility. 
Results Positive BrdU cells were identified in infarcted areas at 4, 14 and 26 days of BM 
transplanted animals. Muscle cells @-actink positive cells) in the scar tissue were 
21.1+15.7 /mm2 in the BM group and 13.6k2.4 /mm2 in the saline group at 26 days 
(p=O.O7). At 26 days the number of endothellal cells (factor VIII positive cells) was 
greater in the BM group than in the saline group (19.5&.9 vs. 6.9i15.1 cells/m& 
p=O.O7). Capillaries >b@m at 28 days were 10.95*3.02 /mm2 in the BM group and 
4.6+0.4 /mm2 in the saline group (p=O.Ol). Wall Motion Score Index was 2.0*0.1 at base- 
line and 2.3+0.12 at 28 days in the BM group (p=O.lS) and 2.OkO.l in the saline group at 
26 days, (p=O.40 vs BM). 
Conclusion: Bone marrow cell engraftment is feasible with viable transplanted cells at 
28 days within scar tissue of non-reperfused myocardial Infarction. Angiogenesis was 
improved after BM inlectlon. However, higher muscle cell area and vascular density in 
the scar were not correlated with improvement of left ventricular function at 26 days. 
1178-140 Caldesmon Regulates Apoptosis and Cell Cycle 
Progression in Capillary Endothelial Cells and Inhibits 
Angiogenesis In Vitro 
Yasushl Numaauchl, Sui Huang, Donald E. Ingber, Children’s Hospital/Harvard Medical 
School, Boston, MA 
Capillary endothelial (CE) cells can be switched between growth and apoptosis by modu- 
lating their shape and cytoskeleton (CSK) using micropatterned adhesive islands (SCI- 
ence 1997; 276:1425-1426). To further examine how the CSK contributes to this 
switching mechanism, we used an adenoviral vector carrying caldesmon, which inhibits 
CSK tension generation antagonizing Rho activity and disassembles acto-myosin fila- 
ments when overexpressed. Associated changes in cell shape and CSK organization 
were visualized tn living cells by expressmg GFP-caldesmon under tight control of a Tet- 
off system. Increase in cellular GFP-caldesmon resulted in progressive loss of actin 
stress fibers, disassembly of focal adhesions and cell retraction; the most highly 
retracted cells covered about one-third the project cell area of controls. The apoptotic 
Index measured by quantitating TUNEL stammg increased in parallel as GFP-caldesmon 
levels were increased and cell retraction was promoted. The smallest cells exhiblted lev- 
els of apoptosis similar to that observed during anoikis in fully detached cells (42 vs. 55% 
TUNEL staining. respectively). Conversely, cell cycle progression into S phase (monl- 
tored by nuclear incorporation of BrdU at 24 hr) decreased from 35 to 9% as cells were 
progressively rounded up under similar conditions. In chicken aollic ring assay, GFP- 
caldesman transfectlon inhibited vascular sprouting up to 60% if compared with those of 
GFP alone or control (5.2mm vs. 10.5mm vs. 12.lmm diameter of sprouting area, 
respectively). These data confirm that the CSK mediates the mechanism by which extra- 
cellular matrix-dependent changes in cell shape influence CE cell growth and apoptosis 
during angiogenesis. The adenoviral vectors encoding GFP-caldesmon under Tet-off 
control also may prove useful in future studies analyzing the role of CSK tension and 
structure during control of capillary development in angiogenesis. 
1178-141 Can Vascular Endothelial Growth Factor Improve Blood 
Flow in Diabetes? 
Ariel Roauln, Samy Nltecki, lrlt Rubinsteln, Edmond Sabo, Zaid A. Abassl, Nina S. Levy, 
Aaron Hoffman, Andrew P. Levy, Technion IIT, Haifa, Israel, Rambam Medical Center. 
Halfa, Israel 
Diabetes Mellitus (DM) is associated with increased cardiovascular morbidity and mortal- 
ity. Collaterals can protect from ischemia. ConsIderable debate exists concerning the 
size and extent of the collateral circulation in DM. Our aim was to evaluate the usefulness 
of continuous oerimuscular infiltration of naked-DNA encodina VEGF. to auament collat- 
era1 formation and tissue perfusion in a DM mouse unilateral ischemic hindlimb model. 
Methods: DM was induced with StreDtozotocin (80 ma/ka). An osmotic DU~D with saline 
I I I  
or 500microgram VEGF was implanted intra-abdomrnaly with an outlet-tube fenestrated 
and tunneled Into the muscle. Ischemiclnormal limb blood flow was measured using a 
laser Doppler blood flowmeter once a week, tissues were analyzed for smooth muscle 
actin and factor-6. DM mice were compared to normal mice. 
Results: In normal mice, a faster restoratIon of blood flow was observed in the VEGF 
treated, however in the DM mice, there was no difference in the rate of flow restoration 
between the VEGF-treated or placebo-treated arm (graph). The blood flow was almost 
complete for the normal mice but reached a ratio of 0.6-0.9 for both DM arms and for nor- 
mal placebo. The blood vessel density was higher for the both DM arms compared to the 
normal mice. 
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Conclusion: Our results demonstrate the rapid and successful restoration of blood flow 
using naked-DNA encoding VEGF in a normal mice but lack of benefit of VEGF adminis- 
tration in DM mice. This may have major implication on angiogenic treatment in patients 
with DM. 
1178-142 IL-6 Is Produced by Splenocytes Derived From CMV- 
Infected Mice in Response to CMV Antigens, and 
Induces MCP-1 Production by Endothelial Cells: A New 
Mechanistic Paradigm for Infection-Induced 
Atherogenesis 
David Rot1 Jianhui Zhu, Mary Susan Burnett, Yi Fu Zhou. Alexandra Zalles-Ganley, 
Stephen E. Epstein, Washington Hospital Center, Washington, DC 
Background: Atherosclerosis is an inflammatory disease. One of the candidate inflamma- 
tory triggers is infection. To further characterize the Interaction between infection, cytok- 
me induction, and atherosclerosis, we tested the hypothesis that cytomegalovirus (CMV) 
infection induces the pro-inflammatory cytokine interleukin-6 (IL-6), which in turn induces 
“pro-atherosclerotic” changes in vascular endothelial cells (ECs). 
Methods: ELISA was used to determine the levels of monocyte chemoattractant protein- 
1 (MCP-1) in the supernatant of mouse and human ECs incubated with IL-6, and IL-6 lev- 
els I” supematants of splenocytes, derived from CMV infected and unmfected mice, stim- 
ulated with mouse CMV antigens. 
Results: IL-6 Induced, in a dose response fashion, MCP-1 expression in human ECs: 0, 
2, 10, and 50 pg/ml IL-6 increased MCP-1 levels in EC conditioned medium from 
1120+65, to 1148+105. 1395i40, and 2119*130 pg/ml, respectively, (P trend < 0.001). 
IL-6 also induced MCP-1 expression in mouse ECs (p<O.O02). Importantly, IL-6 concen- 
tration in the supernatants of splenocyies stimulated with CMV antigens rose from unde- 
tectable levels in uninfected mice to14.925 pglml in the infected mice (P<O.O4). 
Conclusions: These results suggest a previously unrecognized, but potentially important 
mechanism whereby CMV, and other pathogens, contribute to atherogenesls: T-lympho- 
cytes, clonally expanded in response to antigens presented by CMV infection, home to 
sites of vascular injury and locally release IL-6 when presented with either pathogen anti- 
gens that may be present in the plaque, or when they cross-react with host peptides 
homologous to the relevant pathogen antlgens; IL-6 then triggers ECs to release MCP-1, 
which recruits more monocytes and T-cells into the vessel wall and thereby exacerbates 
local inflammation, and thus atherogenesis. 
1178-143 Angiogenesis Induced by Human Hepatocyte Growth 
Factor Gene Without Nitric Oxide Synthesis in a Rat 
lschemic Hindlimb Model 
Makoto lshizawa Koji Ohmori, Takahisa Noma, Teppei Tsuji, Kazushi Murakami, 
Tsunetatsu Namba, Katsufumi Mizushlge, Ryulchi Monshita, Yasufumi Kaneda. 
Masakazu Kohno, Kagawa Medical University, Kagawa. Japan, Osaka University 
Medical School, Suita, Japan 
Background:Vascular endothelial growth factor has been reported that it has the effect 
of angiogenesis through the nitric oxide (NO). Hepatocyte growth factor (HGF) has also 
been reported to have the effect of anglogenesis. However, it has not been reported 
whether HGF induces anglogenesis through the NO. In this study, we examined the fea- 
sibility of gene therapy using the HGF gene to treat peripheral arierlal disease model rat 
in chronically inhibition of NO synthesis. 
Methods: L-NAME (NO synthesis inhibitor) was obtained by drinking water (Img/ml) 
from before resection of left femoral artery throughout this expenment. Sprague-Dawley 
rats were divided into three groups, which were transfected Human HGF naked plasmid 
DNA vector (5OOflg) or control vector (5O@g) with L-NAME administration, and control 
vector without L-NAME administration. The naked plasmid was transfected Into an 
ischemtc hindlimb by intramuscular injection at 1 week after resection. At 4 weeks after 
transfection, angiogenesis were assessed by angiography and tissue capillary density. 
Results:At 4 weeks after transfection. blood pressure was significantly increased in rats 
administrated with L-NAME. but HGF transfection by intramuscular Injection was not 
effect on blood pressure. The human HGF vector transfected rats administrated with L- 
NAME was resulted in significant increase in peripheral blood flow assessed by angiog- 
raphy compared with control vector administrated with L-NAME. Consistent with the 
increase in blood flow, a significant increase in tissue capillary number could be detected 
